Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.47) per share which met the analyst consensus estimate. The company reported quarterly sales of $3.925 million which missed the analyst consensus estimate of $4.134 million by 5.05 percent.
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.47) per share which met the analyst consensus estimate. The company reported quarterly sales of $3.925 million which missed the analyst consensus estimate of $4.134 million by 5.05 percent.
Comments